The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells

By Yoshida D.   Koketshu K   Nomura R.   Teramoto A.  

Journal of Neuro-Oncology, Vol. 100, Iss. 1, 2010-10 ,pp. : 51-64

Springer Publishing Company

Access to resources Recommend Favorite

AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments

By                  

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 33-42

Spandidos Publications

Access to resources Recommend Favorite

SDF-1-CXCR4 axis: Cell trafficking in the cancer stem cell niche of head and neck squamous cell carcinoma

By            

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2325-2331

Spandidos Publications

Access to resources Recommend Favorite

Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine

By Mayr Christian   Neureiter Daniel   Pichler Martin   Berr Frieder   Wagner Andrej   Kiesslich Tobias   Namberger Konrad  

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-08 ,pp. : 2247-2252

Spandidos Publications

Access to resources Recommend Favorite

Functional effects of SDF-1α on a CD44+ CXCR4+ squamous cell carcinoma cell line as a model for interactions in the cancer stem cell niche

By          

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 579-584

Spandidos Publications

Access to resources Recommend Favorite